Area of research
Pharmacology · Genetics
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Genetic Associations and Epidemiology, Hormonal Regulation and Hypertension, and Antiplatelet Therapy and Cardiovascular Diseases.
Discovery of ancestry-specific variants associated with clopidogrel response among Caribbean Hispanics
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry
Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics
Warfarin Dosing in Patients With <i>CYP2C9*5</i> Variant Alleles
Implementation of pharmacogenomics into inpatient general medicine
Why African Americans Say “No”: A Study of Pharmacogenomic Research Participation
Genetic Factors Influencing Warfarin Dose in Black‐African Patients: A Systematic Review and Meta‐Analysis
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations
Hepatocyte gene expression and DNA methylation as ancestry-dependent mechanisms in African Americans
The <scp>ACCO</scp>u<scp>NT</scp> Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans
Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
Novel genetic predictors of venous thromboembolism risk in African Americans
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms
Factors Influencing Pharmacokinetics of Warfarin in African–Americans: Implications for Pharmacogenetic Dosing Algorithms
Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans
Warfarin Pharmacogenetics: An Illustration of the Importance of Studies in Minority Populations
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans
Pathway analysis of genome-wide data improves warfarin dose prediction
VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians
CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects
The Future of Warfarin Pharmacogenetics in under-represented Minority Groups
Effect of <i>NQO1</i> and <i>CYP4F2</i> Genotypes on Warfarin Dose Requirements in Hispanic–Americans and African–Americans
The limits of genome-wide methods for pharmacogenomic testing